论文已发表
注册即可获取德孚的最新动态
IF 收录期刊
Authors Peng X, Guan L, Gao B
Received 25 July 2018
Accepted for publication 12 September 2018
Published 7 December 2018 Volume 2018:11 Pages 8865—8874
DOI https://doi.org/10.2147/OTT.S181433
Checked for plagiarism Yes
Review by Single-blind
Peer reviewers approved by Dr Amy Norman
Peer reviewer comments 3
Editor who approved publication: Dr Sanjeev Srivastava
Background: miR-19 is
a critical carcinogenic miRNA that participates in important biological
processes of human malignancies. CBX7 plays a key role in lung cancer
development and progression. In the present study, for the first time, we
investigated the correlation between miR-19 and CBX7 in non-small-cell lung
cancer (NSCLC).
Methods: miR-19
expression in NSCLC tissues and lung cancer cell lines was detected using
quantitative reverse transcriptase PCR (qRT-PCR). Luciferase reporter assay,
qRT-PCR, Western blot, and immunohistochemical assay were conducted to identify
the target reaction of miR-19 and CBX7. Moreover, the influence of miR-19 on
lung cancer cell proliferation, migration, and invasion was studied including
cell counting kit-8 assay, scratch assay, transwell assay, flow cytometry
assay, and staining assays.
Results: miR-19
was overexpressed in NSCLC tissues and lung cancer cell lines. Luciferase
reporter assay demonstrated that miR-19 could inhibit CBX7 expression via
binding to the 3'-UTR of CBX7. Furthermore, miR-19 remarkably decreased CBX7
protein and mRNA expression. Additionally, overexpression of miR-19 could
significantly enhance lung cancer cell proliferation and migration.
Conclusion: miR-19
functions as a tumor accelerator promoting lung cancer cell proliferation
through targeting CBX7 and inhibiting its expression.
Keywords: miR-19,
NSCLC, CBX7, proliferation
